Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
A new paper in the journal Radiation Oncology provides data on a series of 41 men treated with stereotactic body radiation therapy for intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: body, CyberKnife, intermediate, radiatio, risk, SBRT, stereotactic | Leave a Comment »
Many regular readers may be interested in a blog post by Gary Schwitzer on the MedPage Today web site. It addresses the increasing advertising of CyberKnife radiation therapy (a form of stereotactic body radiation therapy or SBRT) as a first-line treatment for prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: advertising, CyberKnife, promotion, SBRT | 2 Comments »
Data reported by Meier et al. and presented at the recent annual meeting of the American Society for Radiation Oncology (ASTRO) provide some early guidance on the efficacy and safety of sterotactic body radiation therapy (SBRT) in treatment of men with intermediate-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: body, CyberKnife, intermediate risk, localized, radiation, SBRT, stereotactic | Leave a Comment »
Data from a large, retrospective, multi-center study of stereotactic body radiation therapy (SBRT) with CyberKnife technology in the treatment of men with localized prostate cancer were presented on Wednesday afternoon at the annual meeting of the American Society for Radiation Oncology (ASTRO). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, efficacy, outcome, radiation, SBRT, stereotactic, therapy | 1 Comment »
A new paper in the Journal of Oncology Practice has attempted to compare the cost-effectiveness of stereotactic body radiation therapy (SBRT) to that of intensity-modulated radiation therapy (IMRT) in the treatment of men with low- to intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: cost, efficacy, IMRT, intermediate risk, localized, low risk, outcome, SBRT | 3 Comments »
According to a media release from Accuray, Inc., the company has initiated a multi-center, multinational clinical trial in Europe to compare the outcomes of patients with localized prostate cancer treated with CyberKnife stereotactic body radiation therapy (SBRT), da Vinci robot-assisted laparoscopic surgery (RALP), manual laparoscopic surgery (LRP), and conventionally fractionated intensity modulated radiation therapy (IMRT). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: CyberKnife, IMRT, radiation, SBRT, surgery, trial | 3 Comments »
Published reports on the safety and efficacy of extreme hypofactionated radiation therapy (stereotactic body radiation therapy or SBRT, a.k.a. CyberKnife radiation therapy) have, to date, come from just a couple of key centers. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: CyberKnife, outcome, SBRT, stereotactic body radiation therapy | 2 Comments »
Over the past 20 years there has been an explosion in the different ways that we use varied types of external beam radiation therapy for the treatment of localized and locally advanced forms of prostate cancer. Where is the newly diagnosed patient able to find a good, basic introduction? … READ MORE …
Filed under: Management, Treatment | Tagged: 3D-CRT, CyberKnife, EBRT, external beam radiation therapy, IGRT, IMRT, introduction, PBRT, SBRT, TomoTherapy | 2 Comments »
Most published data on the use of stereotactic body radiation therapy (SBRT; CyberKnife radiation therapy) has been based on a total radiation dose of 32 to 38 Gy delivered in a series of four or five sessions — as compared to the delivery of more like 75 to 80 Gy using intensity-modulated radiation (IMRT) and other forms of targeted external beam radiation therapy (EBRT). … READ MORE …
Filed under: Management, Treatment | Tagged: CyberKnife, dose, escalation, outcome, SBRT, stereotactic body radiation therapy | 2 Comments »
In February this year we reported initial 4- and 5-year follow-up data from two US-based research teams on the use of stereotactic body radiation therapy (SBRT or CyberKnife radiation) as a treatment for prostate cancer. A new study from a Korean research group appears to confirm the earlier findings. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: body, localized, outcome, SBRT, stereotactic | 3 Comments »
Over 200 posters and other presentations of new data, as well as many other discussions and lectures, were offered yesterday in the prostate cancer sessions at the Genitourinary Cancers Symposium in Orlando.
… READ MORE
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: adjuvant, ADT, bicalutamide, CyberKnife, dutasteride, intermittent, pomegranate, SBRT, screening | 1 Comment »
Two posters presented today at the Genitourinary Cancers Symposium have extended our knowledge about outcomes after stereotactic body radiation therapy (SBRT or CyberKnife therapy) for localized disease. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: CyberKnife, outcome, SBRT, stereotactic body radiation therapy | 3 Comments »
New data from the radiotherapy group at the University of Califronia, San Francisco suggests that stereotactic body radiation (SBRT) can be used to deliver a “boost” of focused radiation after external beam radiation therapy (EBRT). High dose rate (HDR) brachytherapy has also been used in this way in the past. … READ MORE …
Filed under: Management, Treatment | Tagged: boost, SBRT, stereotactic body radiation therapy | 1 Comment »
A new article in Radiation Oncology provides initial 5-year outcomes of patients treated with stereotactic body radiation therapy (SBRT), also known as CyberKnife therapy. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: CyberKnife, outcome, SBRT, sterotactic body radiation therapy | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site